Clinical Trial Update: The BASE Study: Bicarbonate Administration to Stabilize Estimated Glomerular Filtration Rate (eGFR) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating bicarbonate administration to stabilize eGFR in chronic kidney disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Bicarbonate administration

Snippet

Sponsor: Jennifer Gassman, PhD | Conditions: Chronic Kidney Disease | Phase 3 | Status: COMPLETED | Results posted: 2020-10-20